[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 794 Introduced in Senate (IS)]
<DOC>
118th CONGRESS
2d Session
S. RES. 794
Designating September 25, 2024, as ``National Ataxia Awareness Day'',
and raising awareness of ataxia, ataxia research, and the search for a
cure.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
August 1, 2024
Mrs. Hyde-Smith (for herself, Mr. Murphy, Mrs. Capito, and Ms.
Stabenow) submitted the following resolution; which was referred to the
Committee on the Judiciary
_______________________________________________________________________
RESOLUTION
Designating September 25, 2024, as ``National Ataxia Awareness Day'',
and raising awareness of ataxia, ataxia research, and the search for a
cure.
Whereas ataxia is a clinical manifestation indicating degeneration or
dysfunction of the brain that negatively affects the coordination,
precision, and accurate timing of physical movements;
Whereas ataxia can strike individuals of all ages, including children;
Whereas the term ``ataxia'' is used to classify a group of rare, inherited
neurodegenerative diseases including--
(1) ataxia telangiectasia;
(2) episodic ataxia;
(3) Friedreich's ataxia; and
(4) spinocerebellar ataxia;
Whereas there are many known types of genetic ataxia, but the genetic basis for
ataxia in some patients is still unknown;
Whereas all inherited ataxias affect fewer than 200,000 individuals in the
United States and, therefore, are recognized as rare diseases under the
Orphan Drug Act (Public Law 97-414; 96 Stat. 2049);
Whereas some genetic ataxias are inherited in an autosomal dominant manner while
others are inherited in an autosomal recessive manner;
Whereas ataxia symptoms can also be caused by noninherited health conditions and
other factors, including stroke, tumor, cerebral palsy, head trauma,
multiple sclerosis, alcohol addiction or misuse, and certain
medications;
Whereas ataxia can present physical, psychological, and financial challenges for
patients and their families;
Whereas symptoms and outcomes of ataxia progress at different rates and can
include--
(1) lack of coordination;
(2) slurred speech;
(3) cardiomyopathy;
(4) scoliosis;
(5) eye movement abnormalities;
(6) difficulty walking;
(7) tremors;
(8) trouble eating and swallowing;
(9) difficulties with other activities that require fine motor skills;
and
(10) death;
Whereas many patients with ataxia require the use of assistive devices, such as
wheelchairs and walkers, to aid in their mobility, and many individuals
with ataxia may need physical and occupational therapy;
Whereas few treatments and no cures have been approved for ataxia; and
Whereas clinical research to develop safe and effective treatments for ataxia is
ongoing: Now, therefore, be it
Resolved, That the Senate--
(1) recognizes the need for greater public awareness of
ataxia;
(2) designates September 25, 2024, as ``National Ataxia
Awareness Day'';
(3) supports the goals of National Ataxia Awareness Day,
which are--
(A) to raise awareness of the causes and symptoms
of ataxia among the general public and health care
professionals;
(B) to improve diagnosis of ataxia and access to
care for patients affected by ataxia; and
(C) to accelerate ataxia research, including on
safe and effective treatment options and, ultimately, a
cure;
(4) recognizes the individuals in the United States who
face challenges due to having ataxia, and the families of those
individuals; and
(5) encourages States, territories, and localities to
support the goals of National Ataxia Awareness Day.
<all>